<DOC>
	<DOCNO>NCT00948987</DOCNO>
	<brief_summary>The purpose research study people respond benefit aspirin therapy . The benefit aspirin cardioprotection , decrease risk heart attack and/or stroke . Aspirin work disable platelet , part blood cell use clotting , stick together form blood clot , thus protect heart . It observe failure respond aspirin therapy occur 10 % general population despite take aspirin everyday , group non- responder get protection heart . The investigator would like determine happens .</brief_summary>
	<brief_title>Mechanism Based Resistance Aspirin</brief_title>
	<detailed_description />
	<mesh_term>Aspirin</mesh_term>
	<criteria>Age 18 55 Subjects must good health base medical history , physical examination , vital sign , laboratory test . All subject must non smoke volunteer Female subject child bear potential must use medically acceptable method contraception ( oral contraception , depoprovera injection , IUD , condom spermicide , diaphragm , cervical cap , progestin implant , abstinence , tubal ligation , oophorectomy , TAH ) throughout entire study period . All female subject must consent urine pregnancy test screen prior start treatment phase study , must negative time point . Subjects must within 30 % ideal body weight . Female subject pregnant nursing child . Subjects , receive experimental drug , use experimental medical device within 30 day prior screen , give blood donation â‰¥ one pint within 8 week prior screen . Subjects coagulation , bleed blood disorder . Subjects sensitive allergic aspirin well component . Subjects document history gastrointestinal disorder , include bleed ulcer . Subjects evidence cancer . Subjects history heart disease , include myocardial infarction , angina , coronary artery disease , evidence coronary artery stenosis , arrhythmia , heart failure , CABG Subjects renal , hepatic , respiratory , endocrine , metabolic , hematopoietic neurological disorder . Subjects abnormal laboratory value physical find accord investigator may interfere interpretation study result , indicative underlying disease state , compromise safety potential subject . Subjects history drug alcohol abuse within last 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>aspirin resistance</keyword>
	<keyword>cardiovascular risk</keyword>
	<keyword>prostaglandin</keyword>
	<keyword>platelet inhibition</keyword>
</DOC>